Literature DB >> 8656024

Expression and potential role of E-cadherin in pancreatic carcinoma.

R J Weinel1, K Neumann, O Kisker, A Rosendahl.   

Abstract

CONCLUSION: Our results indicate that loss of E-cadherin might be associated with a more invasive phenotype in pancreatic cancer.
BACKGROUND: A reduced expression of the calcium-dependent E-cadherin cell-cell adhesion molecule on tumor cells has been described as an important factor for tumor invasion and metastasis.
METHODS: Pancreatic tissues (carcinoma, chronic pancreatitis, and normal) as well as 12 pancreatic tumor cell lines were investigated for E-cadherin expression by immunohistochemistry. To correlate the motility of pancreatic tumor cells in vitro with E-cadherin expression, we used a Boyden chamber assay.
RESULTS: In pancreatic carcinoma tissues, diffuse growing tumor cells showed a decrease or loss of E-cadherin expression, whereas in areas of compact tumor growth, only a slight decrease of E-cadherin was observed compared to normal pancreas or chronic pancreatitis. No correlation between the E-cadherin expression and the grading of the tumor cells, the tumor stage, or the disease progression was detectable. Of four tumor cell lines that migrated in the Boyden chamber, three were predominantly E-cadherin negative. In contrast, seven of eight cell lines that did not migrate in vitro revealed E-cadherin expression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8656024     DOI: 10.1007/BF02788372

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


  28 in total

1.  Establishment of a continuous tumor-cell line (panc-1) from a human carcinoma of the exocrine pancreas.

Authors:  M Lieber; J Mazzetta; W Nelson-Rees; M Kaplan; G Todaro
Journal:  Int J Cancer       Date:  1975-05-15       Impact factor: 7.396

2.  Identification of a neural alpha-catenin as a key regulator of cadherin function and multicellular organization.

Authors:  S Hirano; N Kimoto; Y Shimoyama; S Hirohashi; M Takeichi
Journal:  Cell       Date:  1992-07-24       Impact factor: 41.582

3.  Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role.

Authors:  K Vleminckx; L Vakaet; M Mareel; W Fiers; F van Roy
Journal:  Cell       Date:  1991-07-12       Impact factor: 41.582

4.  E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis.

Authors:  J H Schipper; U H Frixen; J Behrens; A Unger; K Jahnke; W Birchmeier
Journal:  Cancer Res       Date:  1991-12-01       Impact factor: 12.701

5.  Relationship between e-cadherin expression and lymph-node metastasis in human esophageal cancer.

Authors:  M Miyata; H Shiozaki; K Iihara; K Shimaya; H Oka; T Kadowaki; M Inoue; S Tamura; M Takeichi; T Mori
Journal:  Int J Oncol       Date:  1994-01       Impact factor: 5.650

6.  Exon skipping in the E-cadherin gene transcript in metastatic human gastric carcinomas.

Authors:  K F Becker; M J Atkinson; U Reich; H H Huang; H Nekarda; J R Siewert; H Höfler
Journal:  Hum Mol Genet       Date:  1993-06       Impact factor: 6.150

7.  Structural analysis of a new highly metastatic cell line PaTu 8902 from a primary human pancreatic adenocarcinoma.

Authors:  H P Elsässer; U Lehr; B Agricola; H F Kern
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1993

8.  Characterization of the tumorigenic and metastatic properties of a human pancreatic tumor cell line (AsPC-1) implanted orthotopically into nude mice.

Authors:  M H Tan; T M Chu
Journal:  Tumour Biol       Date:  1985

9.  Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade, and advanced stage.

Authors:  M Pignatelli; T W Ansari; P Gunter; D Liu; S Hirano; M Takeichi; G Klöppel; N R Lemoine
Journal:  J Pathol       Date:  1994-12       Impact factor: 7.996

10.  A functional assay for proteins involved in establishing an epithelial occluding barrier: identification of a uvomorulin-like polypeptide.

Authors:  B Gumbiner; K Simons
Journal:  J Cell Biol       Date:  1986-02       Impact factor: 10.539

View more
  13 in total

Review 1.  Current approaches and future strategies for pancreatic carcinoma.

Authors:  R A Wolff; P Chiao; R Lenzi; P W Pisters; J E Lee; N A Janjan; C H Crane; D B Evans; J L Abbruzzese
Journal:  Invest New Drugs       Date:  2000-02       Impact factor: 3.850

2.  Type I collagen and divalent cation shifts disrupt cell-cell adhesion, increase migration, and decrease PTHrP, IL-6, and IL-8 expression in pancreatic cancer cells.

Authors:  John J Grzesiak; Kathy C Smith; Cheryl Chalberg; Douglas W Burton; Leonard J Deftos; Michael Bouvet
Journal:  Int J Gastrointest Cancer       Date:  2005

3.  Fluorescence in situ hybridization using an old world monkey Y chromosome specific probe combined with immunofluorescence staining on rhesus monkey tissues.

Authors:  Xiujin Xia; Terri Rasmussen; Xavier Alvarez; Takahiro Taguchi; Marilyn Li; Vincent F La Russa
Journal:  J Histochem Cytochem       Date:  2007-06-26       Impact factor: 2.479

4.  Effector T lymphocyte subsets in human pancreatic cancer: detection of CD8+CD18+ cells and CD8+CD103+ cells by multi-epitope imaging.

Authors:  K Ademmer; M Ebert; F Müller-Ostermeyer; H Friess; M W Büchler; W Schubert; P Malfertheiner
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

5.  Propofol inhibits growth and invasion of pancreatic cancer cells through regulation of the miR-21/Slug signaling pathway.

Authors:  Zimin Liu; Jian Zhang; Guangchen Hong; Jinping Quan; Lin Zhang; Meiqin Yu
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

6.  Inhibition of growth and metastatic progression of pancreatic carcinoma in hamster after somatostatin receptor subtype 2 (sst2) gene expression and administration of cytotoxic somatostatin analog AN-238.

Authors:  N Benali; P Cordelier; D Calise; P Pages; P Rochaix; A Nagy; J P Esteve; P M Pour; A V Schally; N Vaysse; C Susini; L Buscail
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

7.  [Use of silicon chip technology to detect protein-based tumor markers in bladder cancer].

Authors:  T Jäger; T Szarvas; F vom Dorp; C Börgermann; M Schenck; K W Schmid; H Rübben
Journal:  Urologe A       Date:  2007-09       Impact factor: 0.639

8.  Integrin-mediated laminin-1 adhesion upregulates CXCR4 and IL-8 expression in pancreatic cancer cells.

Authors:  John J Grzesiak; Kathy C Smith; Douglas W Burton; Leonard J Deftos; Michael Bouvet
Journal:  Surgery       Date:  2007-05-04       Impact factor: 3.982

9.  Adhesion molecules and p16 expression in endocervical adenocarcinoma.

Authors:  Elisabetta Carico; Franco Fulciniti; Maria Rosaria Giovagnoli; Nunzia Simona Losito; Gerardo Botti; Giulio Benincasa; Maria Giuseppina Farnetano; Aldo Vecchione
Journal:  Virchows Arch       Date:  2009-08-13       Impact factor: 4.064

10.  Absence of E-cadherin expression distinguishes noncohesive from cohesive pancreatic cancer.

Authors:  Jordan M Winter; Angela H Ting; Felip Vilardell; Eike Gallmeier; Steve B Baylin; Ralph H Hruban; Scott E Kern; Christine A Iacobuzio-Donahue
Journal:  Clin Cancer Res       Date:  2008-01-15       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.